Opto Circuits' US Subsidiary Cardiac Science Wins Large European AED Contract

BENGALURU, India and BOTHELL, Wash., April 27, 2011 /PRNewswire/ -- The wholly-owned subsidiary of Opto Circuits (India) Ltd., Cardiac Science Corporation, a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, has been awarded a contract to deploy 650 Powerheart® AEDs in Girona, Spain, home to 700,000 Catalonians. With this initiative, Girona becomes the first Spanish city to implement a wide network of defibrillators to protect its citizens against sudden cardiac arrest.

Dipsalut, the Public Health organization of the Girona Council (Organismo de Salud Publica de la Diputacion de Girona), estimates more than 3,000 Catalonians die from sudden cardiac arrest each year. A defibrillating shock administered within one minute after cardiac arrest increases the chance of survival to 90 percent, according to the European Resuscitation Council.

Cardiac Science and a valued partner MC Infortecnica worked together to win the Girona contract, a decision made with input from the Brugada Foundation, the University of Girona Faculty of Medicine and the Emergency Medical System of Catalonia.

"We are pleased to partner with Dipsalut in providing AEDs that will protect the Girona community," says Cardiac Science CEO, Dave Marver. "We believe our fully automatic Powerheart AED G3 Plus is the best technology for any large-scale public access defibrillation (PAD) program."

Dipsalut also ordered 500 "intelligent" AED cabinets. When a cabinet is opened to access an AED, a signal is automatically sent to alert the local emergency medical response team.

Most of the fully automatic Cardiac Science AEDs will be deployed in streets or public squares. Other defibrillators will be used to protect high-risk facilities such as sports centers, train stations, airports and bus stations.

About: Cardiac Science

Cardiac Science, a wholly owned subsidiary of Opto Circuits (India) Ltd.,  develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AED), electrocardiograph devices (ECG/EKG), cardiac stress treadmill and systems, PC-based diagnostic workstations, Holter monitoring systems, hospital defibrillators, vital signs monitors, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The company sells a variety of related products and consumables and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick®, HeartCentrix®, Powerheart® and Quinton® brands, is headquartered in Bothell, Washington. With customers in almost 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.

For updates and information on worldwide defibrillation and cardiac monitoring, find us on the Cardiac Science blog at http://www.cardiacscience.com/blog, Twitter at http://twitter.com/cardiacscience, Facebook at http://budurl.com/CSonFB and YouTube at http://budurl.com/CSonYT.

For more information, contact (media) [email protected] +1.425.402.2092 | (investors) [email protected] | +91.80.2852.8088

LOGO: http://www.cardiacscience.com/images/main_logo.gif

SOURCE Cardiac Science